This is research, not a buy or sell recommendation. Robo-advice in Taiwan requires an FSC licence; FEAF analyses, explains and monitors, and the investor makes the decision. Judgement thresholds are working rules pending review by the team's finance members.
Plain-language summary of valuation, growth, profitability, balance sheet, and recent MOPS filings.
Your risk profile
Conclusion
Mixed picture: 5 strengths against 1 watch-outs. Weigh them against your own goals.
For a moderate profile, none of the items above crosses the watch-out thresholds set by the team.
No model narrative: the model call failed. The structured analysis above is complete on its own.
Strengths
+
The current price implies -5.1% perpetual growth, within the 3.5% ceiling: expectations look attainable. source (Valuation) →
+
P/E 10.20 is well below the Chemicals median of 18.46 (26 listed peers): priced cheaper than peers. source (Key Stats) →
+
Return on equity 15.0% with a 26.0% net margin: highly profitable. source (Key Stats) →
+
Liabilities are only 20.0% of total assets (Q3 2026): a light debt load. source (Financials) →
+
Free cash flow was positive in 2025: 2,841 NT$ million. source (Financials) →
Watch-outs
!
Revenue fell -15.8% in 2025; latest quarter Q3 2026: 27.6% year on year. source (Financials) →
What to check before deciding
?Is the revenue decline temporary or structural?